Praxis Investment Management Inc. Sells 1,762 Shares of Humana Inc. $HUM

Posted by Brian Himes on Jul 8th, 2026

Praxis Investment Management Inc. reduced its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 52.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,613 shares of the insurance provider’s stock after selling 1,762 shares during the period. Praxis Investment Management Inc.’s holdings in Humana were worth $280,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of Humana by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after buying an additional 106,030 shares in the last quarter. Capital International Investors grew its position in Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after acquiring an additional 3,097,571 shares during the last quarter. Pzena Investment Management LLC raised its stake in Humana by 34.3% during the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after acquiring an additional 1,398,774 shares in the last quarter. State Street Corp lifted its holdings in shares of Humana by 1.8% in the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after acquiring an additional 97,211 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its holdings in shares of Humana by 28.9% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock worth $1,151,759,000 after acquiring an additional 1,008,514 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

HUM stock opened at $394.39 on Wednesday. The stock has a 50-day moving average price of $329.02 and a 200-day moving average price of $252.29. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $415.00. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The firm has a market cap of $47.35 billion, a PE ratio of 42.18, a price-to-earnings-growth ratio of 2.24 and a beta of 0.71.

Humana (NYSE:HUM – Get Free Report) last announced its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, equities research analysts expect that Humana Inc. will post 9.03 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s payout ratio is presently 37.86%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Seaport Research Partners lowered shares of Humana to a “neutral” rating in a report on Wednesday, May 20th. Jefferies Financial Group upgraded shares of Humana from a “buy” rating to a “buy” rating in a research report on Wednesday, May 20th. Morgan Stanley boosted their target price on shares of Humana from $217.00 to $249.00 and gave the stock an “underweight” rating in a research note on Thursday, June 4th. UBS Group reissued a “neutral” rating on shares of Humana in a report on Monday, June 15th. Finally, Bank of America upped their target price on Humana from $340.00 to $380.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $296.39.

Read Our Latest Analysis on Humana

Humana Profile

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.